EUVIMEDOpdag EUVIMED
Crossref

Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid

Zhiwei Liu iD, Wenxin Shao iD, Xingwen Wang iD, Kuo Geng iD, Wenhui Wang iD, Yiming Li iD, Youjun Chen iD, Haitang Xie iD

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2024

DOI: 10.1002/phar.4603 ↗

At a glance

Journal article in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2024. Written by Zhiwei Liu and 7 co-authors. Institution: Anhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China. Major MEDLINE topics: Lamotrigine, Valproic Acid, Anticonvulsants, Carbamazepine. Cited 6 times so far (Crossref); 41 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Lamotrigine (LTG) is an antiepileptic drug that has been used in pediatric epilepsy as a combination therapy or monotherapy after stabilization in recent years. However, there are significant drug–drug interactions (DDI) between LTG and combined drugs such as carbamazepine (CBZ) and valproic acid (VPA). It is particularly important to consider the risk of DDI in combination therapy for intractable epilepsy in pediatric patients. Therefore, it is necessary to adjust the dosage of LTG accordingly. The aim of this study was to establish and validate a pediatric physiologically based pharmacokinetic (PBPK) model for predicting LTG exposure. The model is designed to explore the potential for quantifying pharmacokinetic (PK) DDI of LTG when administered concurrently with CBZ or VPA in pediatric patients.

Method

Adult and pediatric PBPK models for LTG and VPA were developed using PK‐Sim® software in combination with physiological information and drug‐specific parameters, and a DDI model was developed in combination with the published CBZ model. The models were validated against available PK data.

Results

Predictive and observational results in adults, children, and the DDI model were in good agreement. The recommended doses of LTG for preschool children (2–6 years) and school‐aged children (6–12 years) in the absence of drug interactions were 1.47 and 1.2 times higher than those for adults, respectively; 3.1 and 2.6 times higher than those for adults in combination with CBZ; and 0.67 and 0.57 times lower than those for adults in combination with VPA. In addition, plasma exposures in adolescents (12–18 years) were similar to those in adults at the same doses.

Conclusion

We have successfully developed PBPK models and DDI models for LTG in adults and children, which provide a reference for rational drug use in the pediatric population.

Subjects

MeSH terms (MEDLINE)

LamotrigineValproic AcidAnticonvulsantsCarbamazepineModels, BiologicalDrug InteractionsDrug Therapy, CombinationHumansChildChild, PreschoolAdolescentMaleFemaleAdultEpilepsyDose-Response Relationship, DrugYoung AdultTriazines

Author keywords

carbamazepinedrug interactionslamotriginepediatricphysiologically based pharmacokinetic modelvalproic acid

Substances

LamotrigineValproic AcidAnticonvulsantsCarbamazepineTriazines

Authors and institutions

  • Anhui Provincial Center for Drug Clinical Evaluation, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.
  • Wannan Medical College, Wuhu, China.

ORCID profiles: Zhiwei Liu, Wenxin Shao, Xingwen Wang, Kuo Geng, Wenhui Wang, Yiming Li, Youjun Chen, Haitang Xie

Cite

APA

Liu, Z., Shao, W., Wang, X., Geng, K., Wang, W., Li, Y., Chen, Y., & Xie, H. (2024). Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.4603

Vancouver

Liu Z, Shao W, Wang X, Geng K, Wang W, Li Y, et al. Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2024. doi:10.1002/phar.4603

BibTeX
@article{Liu2024,
  author = {Liu, Zhiwei and Shao, Wenxin and Wang, Xingwen and Geng, Kuo and Wang, Wenhui and Li, Yiming and Chen, Youjun and Xie, Haitang},
  title = {Physiologically based pharmacokinetic models for predicting lamotrigine exposure and dose optimization in pediatric patients receiving combination therapy with carbamazepine or valproic acid},
  journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
  year = {2024},
  doi = {10.1002/phar.4603}
}
Start for free →